Vaccine makers Pfizer and Moderna pledge massive boost to U.S. supply after sluggish rollout

The increases needed to meet March delivery targets will be steep, however, and Biden administration officials expect the companies could come up slightly short.
Health

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.